Accueil
Détail du congrès:
Documents disponibles provenant de ce congrès (4)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; J. MATIAS ; L. MONTANARI ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The Drug-r[...]
Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]
Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]
Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; L. MONTANARI ; B. GUARITA ; A. PIRONA ; I. GIRAUDON ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Comparable and reliable information on the numbers and characteristics of those entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatme[...]
